Bain Capital teams with Pfizer to create new neuroscience-focused company

  • 📰 CNBC
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 72%

Business News News

Business Business Latest News,Business Business Headlines

Pfizer announced in January it planned to shut down early- and mid-stage neuroscience drug development. But now Pfizer and investment firm Bain Capital are creating a new company. Its name: Cerevel Therapeutics.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 12. in BUSÄ°NESS

Business Business Latest News, Business Business Headlines